Target intelligence / Profile preview

2,2-Diphenyl-1-picrylhydrazyl (DPPH)

Target
DPPH
Molecular classification
Stable organic radical, Hydrazyl derivative, Analytical reagent, Chemical probe
01

Overview

2,2-Diphenyl-1-picrylhydrazyl (DPPH) is a stable, synthetic free radical extensively used in pharmaceutical and nutritional research as a chemical probe to evaluate the antioxidant potential of various substances. Characterized by its deep violet color in organic solvents, DPPH possesses an unpaired electron delocalized over the entire molecule, which gives it a strong absorption band around 517 nm [1, 4]. When an antioxidant compound is introduced, it neutralizes the DPPH radical by donating a hydrogen atom or an electron, causing the solution to turn pale yellow or colorless [3, 6]. This transition allows for the quantitative determination of the radical-scavenging efficiency of natural extracts and synthetic drugs using a spectrophotometer [10]. Although DPPH is a standard tool for high-throughput screening of antioxidant activity in vitro, it is not a biological molecule and does not exist in the human body [9, 11]. Consequently, while it serves as a valuable indicator for preliminary drug discovery, it is not a therapeutic target for clinical treatment [10].

Other names
DPPH radical1,1-Diphenyl-2-picrylhydrazyl2,2-Diphenyl-1-(2,4,6-trinitrophenyl)hydrazylDiphenylpicrylhydrazyl
02

Mechanism of action

DPPH acts as a hydrogen atom or electron acceptor. When reacting with an antioxidant, the DPPH radical is reduced to 2,2-diphenyl-1-picrylhydrazine (DPPH-H), resulting in a colorimetric shift from deep violet to pale yellow, which is measured spectrophotometrically at approximately 517 nm [1, 3, 10].

03

Biological functions

None (synthetic molecule)In vitro antioxidant capacity assessmentFree radical scavenging (analytical)
04

Disease associations

None
05

Safety considerations

Synthetic laboratory reagent; not for human consumptionLimited physiological relevance (does not occur naturally in biological systems) [10, 11]Sensitivity to light and solvent type can affect assay reproducibility [11]
06

Interacting drugs

Ascorbic acid (Vitamin C)

6 more in the full profile.

07

Biomarkers

IC50 (Inhibition concentration 50%)Trolox Equivalent Antioxidant Capacity (TEAC)

Beyond the preview

Go deeper on 2,2-Diphenyl-1-picrylhydrazyl (DPPH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,2-Diphenyl-1-picrylhydrazyl (DPPH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call